Shanghai Fosun Pharmaceutical Group Co Ltd (600196) — Long-term Investment Intensity
Shanghai Fosun Pharmaceutical Group Co Ltd (600196) has a Long-term Investment Intensity of 29.9% as of September 2019. Long-term investments of CN¥23.52 Billion represent 29.9% of total assets of CN¥78.57 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See 600196 net asset value for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Shanghai Fosun Pharmaceutical Group Co Ltd Long-term Investment Intensity (2015–2018)
This chart shows how Shanghai Fosun Pharmaceutical Group Co Ltd's Long-term Investment Intensity has evolved across 4 annual periods from 2015 to 2018. As of September 2019, the intensity stands at 29.9%, reflecting long-term investments of CN¥23.52 Billion against total assets of CN¥78.57 Billion CNY. Also explore total assets of Shanghai Fosun Pharmaceutical Group Co L for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Shanghai Fosun Pharmaceutical Group Co Ltd (2015–2018)
The table below presents the year-by-year Long-term Investment Intensity for Shanghai Fosun Pharmaceutical Group Co Ltd from 2015 to 2018, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see 600196 market cap overview.
| Year | LT Investment Intensity | LT Investments (CNY) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 34.1% | CN¥24.06 Billion | CN¥70.55 Billion | ▲ +0.0 pp |
| 2017 | 34.1% | CN¥21.12 Billion | CN¥61.97 Billion | ▼ -9.0 pp |
| 2016 | 43.1% | CN¥18.85 Billion | CN¥43.77 Billion | ▼ -2.0 pp |
| 2015 | 45.1% | CN¥17.23 Billion | CN¥38.20 Billion | — |